Preclinical Efficacy of IMM-BCP-01, a Highly Active Patient-Derived Anti-SARS-CoV-2 Antibody Cocktail
Authors:
- Pavel A. NikitinPNPavel A. Nikitin
- Eden L. SikorskiESEden L. Sikorski
Preprint
Abstract
Using an unbiased interrogation of the memory B cell repertoire of convalescent COVID-19 patients, we identified human antibodies that demonstrated robust antiviral activity in vitro and efficacy in vivo against all tested SARS-CoV-2 variants. Here, we describe the pre-clinical characterization of an antibody cocktail, IMM-BCP-01, that consists of three unique, patient-derived recombinant neutralizing antibodies directed at non-overlapping surfaces on the SARS-CoV-2 spike protein. Two antibodies, IMM20184 and IMM20190 directly block spike binding to the ACE2 receptor. Binding of the third antibody, IMM20253, to its unique epitope on the outer surface of RBD, alters the conformation of the spike trimer, promoting release of spike monomers. These antibodies decreased SARS-CoV-2 infection in the lungs of Syrian golden hamsters, and efficacy in vivo efficacy was associated with broad antiviral neutralizing activity against multiple SARS-CoV-2 variants and robust antiviral effector function response, including phagocytosis, ADCC, and complement pathway activation. Our pre-clinical data demonstrate that the three antibody cocktail IMM-BCP-01 shows promising potential for preventing or treating SARS-CoV-2 infection in susceptible individuals. One sentence summary: IMM-BCP-01 cocktail triggers Spike Trimer dissociation, neutralizes all tested variants in vitro , activates a robust effector response and dose-dependently inhibits virus in vivo .Keywords
This publication has 40 references indexed in Scilit:
- cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determinationNature Methods, 2017
- Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2eLife, 2016
- Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and AntigenMolecular Cell, 2016
- Gctf: Real-time CTF determination and correctionJournal of Structural Biology, 2016
- CTFFIND4: Fast and accurate defocus estimation from electron micrographsJournal of Structural Biology, 2015
- A high‐throughput shotgun mutagenesis approach to mapping B‐cell antibody epitopesImmunology, 2014
- TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutininsBlood, 2014
- Complement Is Activated by IgG Hexamers Assembled at the Cell SurfaceScience, 2014
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesJournal of Immunological Methods, 2011
- Automated molecular microscopy: The new Leginon systemJournal of Structural Biology, 2005